APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cannabinoid-based Antitumor Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cannabinoid-based Antitumor Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026180 pages

Choose your research edition.

Industry ResearchCannabinoid-based Antitumor Drug Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Cannabinoid-based Antitumor Drug Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Cannabinoid-based Antitumor Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cannabinoid-based Antitumor Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cannabinoid-based Antitumor Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Cannabinoid-based Antitumor Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cannabinoid-based Antitumor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cannabinoid-based Antitumor Drug include Cannabics Inc., GW Pharmaceuticals, Jay Pharma, Medicanja Ltd, Tikun Olam and Valeant Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cannabinoid-based Antitumor Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cannabinoid-based Antitumor Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cannabinoid-based Antitumor Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cannabinoid-based Antitumor Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Cannabinoid-based Antitumor Drug Segment by Company

Cannabics Inc.

GW Pharmaceuticals

Jay Pharma

Medicanja Ltd

Tikun Olam

Valeant Pharmaceuticals

Cannabinoid-based Antitumor Drug Segment by Type

Chewing Medicine

Lozenge

Other

Cannabinoid-based Antitumor Drug Segment by Application

Clinics

Hospitals

Others

Cannabinoid-based Antitumor Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid-based Antitumor Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid-based Antitumor Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid-based Antitumor Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cannabinoid-based Antitumor Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cannabinoid-based Antitumor Drug industry.

Chapter 3: Detailed analysis of Cannabinoid-based Antitumor Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabinoid-based Antitumor Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chewing Medicine Table 3. Key Players of Lozenge Table 4. Key Players of Other Table 4. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinics Table 6. Key Players of Hospitals Table 7. Key Players of Others Table 8. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cannabinoid-based Antitumor Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cannabinoid-based Antitumor Drug Market Share by Region (2021-2026) Table 11. Global Cannabinoid-based Antitumor Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cannabinoid-based Antitumor Drug Market Share by Region (2027-2032) Table 13. Cannabinoid-based Antitumor Drug Industry Trends Table 14. Cannabinoid-based Antitumor Drug Industry Drivers Table 15. Cannabinoid-based Antitumor Drug Industry Opportunities and Challenges Table 16. Cannabinoid-based Antitumor Drug Industry Restraints Table 17. Global Cannabinoid-based Antitumor Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Company (2021-2026) Table 19. Global Cannabinoid-based Antitumor Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cannabinoid-based Antitumor Drug Key Company Head Office and Area Served Table 21. Global Cannabinoid-based Antitumor Drug Company, Product Type & Application Table 22. Global Cannabinoid-based Antitumor Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cannabinoid-based Antitumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cannabinoid-based Antitumor Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2021-2026) Table 29. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2027-2032) Table 30. Global Cannabinoid-based Antitumor Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2021-2026) Table 34. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2027-2032) Table 35. Cannabics Inc. Company Information Table 36. Cannabics Inc. Business Overview Table 37. Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Cannabics Inc. Cannabinoid-based Antitumor Drug Product Portfolio Table 39. Cannabics Inc. Recent Development Table 40. GW Pharmaceuticals Company Information Table 41. GW Pharmaceuticals Business Overview Table 42. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio Table 44. GW Pharmaceuticals Recent Development Table 45. Jay Pharma Company Information Table 46. Jay Pharma Business Overview Table 47. Jay Pharma Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Jay Pharma Cannabinoid-based Antitumor Drug Product Portfolio Table 49. Jay Pharma Recent Development Table 50. Medicanja Ltd Company Information Table 51. Medicanja Ltd Business Overview Table 52. Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Medicanja Ltd Cannabinoid-based Antitumor Drug Product Portfolio Table 54. Medicanja Ltd Recent Development Table 55. Tikun Olam Company Information Table 56. Tikun Olam Business Overview Table 57. Tikun Olam Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Tikun Olam Cannabinoid-based Antitumor Drug Product Portfolio Table 59. Tikun Olam Recent Development Table 60. Valeant Pharmaceuticals Company Information Table 61. Valeant Pharmaceuticals Business Overview Table 62. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio Table 64. Valeant Pharmaceuticals Recent Development Table 65. North America Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026) Table 71. North America Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032) Table 72. Europe Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026) Table 78. Europe Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032) Table 79. China Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 80. China Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 81. China Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 82. China Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026) Table 89. Asia Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Cannabinoid-based Antitumor Drug Product Image Figure 2. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cannabinoid-based Antitumor Drug Market Share by Type: 2025 VS 2032 Figure 4. Chewing Medicine Image Figure 5. Lozenge Image Figure 6. Other Image Figure 7. Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cannabinoid-based Antitumor Drug Market Share by Application: 2025 VS 2032 Figure 9. Clinics Image Figure 10. Hospitals Image Figure 11. Others Image Figure 12. Global Cannabinoid-based Antitumor Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Cannabinoid-based Antitumor Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cannabinoid-based Antitumor Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cannabinoid-based Antitumor Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cannabinoid-based Antitumor Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Cannabinoid-based Antitumor Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cannabinoid-based Antitumor Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032) Figure 25. North America Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032) Figure 26. North America Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032) Figure 27. United States Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032) Figure 32. Europe Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032) Figure 33. Europe Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032) Figure 34. Germany Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032) Figure 42. China Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032) Figure 43. Asia Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032) Figure 45. Asia Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032) Figure 46. Asia Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032) Figure 47. Japan Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032) Figure 57. Brazil Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cannabinoid-based Antitumor Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Chewing Medicine
  • Lozenge
  • Other
Applications
  • Clinics
  • Hospitals
  • Others
Companies covered
  • Cannabics Inc.
  • GW Pharmaceuticals
  • Jay Pharma
  • Medicanja Ltd
  • Tikun Olam
  • Valeant Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chewing Medicine
  5. 1.2.3 Lozenge
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cannabinoid-based Antitumor Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinics
  10. 1.3.3 Hospitals
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cannabinoid-based Antitumor Drug Growth Trends by Region
  14. 1.5.1 Global Cannabinoid-based Antitumor Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cannabinoid-based Antitumor Drug Market Size by Region (2021-2026)
  16. 1.5.3 Cannabinoid-based Antitumor Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cannabinoid-based Antitumor Drug Market Dynamics
  1. 2.1 Cannabinoid-based Antitumor Drug Industry Trends
  2. 2.2 Cannabinoid-based Antitumor Drug Industry Drivers
  3. 2.3 Cannabinoid-based Antitumor Drug Industry Opportunities and Challenges
  4. 2.4 Cannabinoid-based Antitumor Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cannabinoid-based Antitumor Drug Revenue by Company (2021-2026)
  2. 3.2 Global Cannabinoid-based Antitumor Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cannabinoid-based Antitumor Drug Key Company Head office and Area Served
  4. 3.4 Global Cannabinoid-based Antitumor Drug Company, Product Type & Application
  5. 3.5 Global Cannabinoid-based Antitumor Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cannabinoid-based Antitumor Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cannabinoid-based Antitumor Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cannabinoid-based Antitumor Drug Tier 1, Tier 2, and Tier 3
4 Cannabinoid-based Antitumor Drug Market by Type
  1. 4.1 Global Cannabinoid-based Antitumor Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cannabinoid-based Antitumor Drug Market Size by Type (2021-2032)
  3. 4.3 Global Cannabinoid-based Antitumor Drug Market Size Share by Type (2021-2032)
5 Cannabinoid-based Antitumor Drug Market by Application
  1. 5.1 Global Cannabinoid-based Antitumor Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cannabinoid-based Antitumor Drug Market Size by Application (2021-2032)
  3. 5.3 Global Cannabinoid-based Antitumor Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cannabics Inc.
  2. 6.1.1 Cannabics Inc. Company Information
  3. 6.1.2 Cannabics Inc. Business Overview
  4. 6.1.3 Cannabics Inc. Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cannabics Inc. Cannabinoid-based Antitumor Drug Product Portfolio
  6. 6.1.5 Cannabics Inc. Recent Developments
  7. 6.2 GW Pharmaceuticals
  8. 6.2.1 GW Pharmaceuticals Company Information
  9. 6.2.2 GW Pharmaceuticals Business Overview
  10. 6.2.3 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 GW Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio
  12. 6.2.5 GW Pharmaceuticals Recent Developments
  13. 6.3 Jay Pharma
  14. 6.3.1 Jay Pharma Company Information
  15. 6.3.2 Jay Pharma Business Overview
  16. 6.3.3 Jay Pharma Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Jay Pharma Cannabinoid-based Antitumor Drug Product Portfolio
  18. 6.3.5 Jay Pharma Recent Developments
  19. 6.4 Medicanja Ltd
  20. 6.4.1 Medicanja Ltd Company Information
  21. 6.4.2 Medicanja Ltd Business Overview
  22. 6.4.3 Medicanja Ltd Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Medicanja Ltd Cannabinoid-based Antitumor Drug Product Portfolio
  24. 6.4.5 Medicanja Ltd Recent Developments
  25. 6.5 Tikun Olam
  26. 6.5.1 Tikun Olam Company Information
  27. 6.5.2 Tikun Olam Business Overview
  28. 6.5.3 Tikun Olam Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Tikun Olam Cannabinoid-based Antitumor Drug Product Portfolio
  30. 6.5.5 Tikun Olam Recent Developments
  31. 6.6 Valeant Pharmaceuticals
  32. 6.6.1 Valeant Pharmaceuticals Company Information
  33. 6.6.2 Valeant Pharmaceuticals Business Overview
  34. 6.6.3 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Valeant Pharmaceuticals Cannabinoid-based Antitumor Drug Product Portfolio
  36. 6.6.5 Valeant Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Cannabinoid-based Antitumor Drug Market Size (2021-2032)
  2. 7.2 North America Cannabinoid-based Antitumor Drug Market Size by Type
  3. 7.2.1 North America Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032)
  6. 7.3 North America Cannabinoid-based Antitumor Drug Market Size by Application
  7. 7.3.1 North America Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032)
  10. 7.4 North America Cannabinoid-based Antitumor Drug Market Size by Country
  11. 7.4.1 North America Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cannabinoid-based Antitumor Drug Market Size (2021-2032)
  2. 8.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type
  3. 8.2.1 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Cannabinoid-based Antitumor Drug Market Size by Application
  7. 8.3.1 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Cannabinoid-based Antitumor Drug Market Size by Country
  11. 8.4.1 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cannabinoid-based Antitumor Drug Market Size (2021-2032)
  2. 9.2 China Cannabinoid-based Antitumor Drug Market Size by Type
  3. 9.2.1 China Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032)
  6. 9.3 China Cannabinoid-based Antitumor Drug Market Size by Application
  7. 9.3.1 China Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cannabinoid-based Antitumor Drug Market Size (2021-2032)
  2. 10.2 Asia Cannabinoid-based Antitumor Drug Market Size by Type
  3. 10.2.1 Asia Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Cannabinoid-based Antitumor Drug Market Size by Application
  7. 10.3.1 Asia Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Cannabinoid-based Antitumor Drug Market Size by Country
  11. 10.4.1 Asia Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cannabinoid-based Antitumor Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst